Hyloris Pharmaceuticals SA
EBR:HYL.BR
5.3 (EUR) • At close February 19, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -6.342 | -15.38 | -10.77 | -11.579 | -7.145 | -5.274 | -5.469 | -3.866 |
| Depreciation & Amortization
| 1.229 | 0.348 | 0.196 | 0.137 | 0.581 | 3.306 | 0.088 | 0.065 |
| Deferred Income Tax
| 0 | -0.294 | 0 | 0.196 | 0.001 | 0 | 0 | -1.329 |
| Stock Based Compensation
| -0.54 | 0.54 | 0.56 | 0.576 | 0.485 | 0 | 0 | 1.329 |
| Change In Working Capital
| -1.278 | 2.234 | -3.375 | -0.777 | 0.031 | -2.589 | 0.013 | 0.856 |
| Accounts Receivables
| -1.681 | 0.029 | -2.261 | -2.068 | 0.081 | 0.808 | -0.925 | -0.178 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 1.05 | -0.468 | 1.138 | -1.398 | -0.218 | 0.936 | 0.777 |
| Other Working Capital
| 0.403 | 1.155 | -0.646 | 0.153 | 1.348 | -3.179 | 0.002 | 0.257 |
| Other Non Cash Items
| 0.228 | -0.256 | 0.235 | 0.197 | 1.477 | -0.005 | 0.485 | 1.329 |
| Operating Cash Flow
| -6.703 | -12.808 | -13.154 | -11.25 | -4.57 | -4.562 | -5.368 | -1.616 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -0.029 | -0.298 | -0.739 | -1.061 | -0.623 | -1.23 | -0.031 | -2.8 |
| Acquisitions Net
| 0 | 0 | 0 | -1.27 | 0 | 0 | 0.05 | 0.062 |
| Purchases Of Investments
| 0 | 0 | -0.5 | -1.178 | -0.01 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 10 | 0.522 | 0.216 | 0 | 0.003 | 0 | 0.002 |
| Other Investing Activites
| 0.288 | 0.187 | -11.793 | 0.218 | -0.633 | -0.001 | 0.05 | -2.736 |
| Investing Cash Flow
| 0.259 | 9.889 | -1.239 | -3.075 | -0.633 | -1.228 | 0.019 | -2.736 |
| Financing Activities: | ||||||||
| Debt Repayment
| -0.168 | 0.051 | -7.376 | -0.062 | 10.143 | 0 | 2.017 | 4.387 |
| Common Stock Issued
| 0 | 0 | 17.169 | 0 | 59.254 | 0 | 5.75 | 0.012 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.2 | -0.182 | -1.955 | 0 | 0 | 3.308 | -0.002 | -0.001 |
| Financing Cash Flow
| -0.368 | -0.131 | 7.838 | -0.062 | 69.397 | 3.308 | 7.765 | 4.398 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 |
| Net Change In Cash
| -6.812 | -3.051 | -6.555 | -14.387 | 64.194 | -2.482 | 2.416 | 0.047 |
| Cash At End Of Period
| 23.594 | 30.406 | 43.457 | 50.012 | 64.399 | 0.205 | 2.687 | 0.271 |